Showing results (571-580 of 641) with videos related to
Sort By:
Pageof 65
Transplantation Proceedings|April 24, 2023
Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver TransplantationKouki Imaoka, Masahiro Ohira, Tomoaki Bekki, et al.Hepato-Gastroenterology|December 24, 2008
Prophylaxis against recurrence of HBV hepatitis after living-donor liver transplantationHirotaka Tashiro, Toshiyuki Itamoto, Yasuhiro Fudaba, et al.Annals of Surgery|December 19, 2023
An Analysis of 10,000 Cases of Living Donor Liver Transplantation in Japan: Special Reference to the Graft-Versus-Recipient Weight Ratio and Donor AgeSusumu Eguchi, Koji Umeshita, Yuji Soejima, et al.Plos One|March 3, 2017
Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virusEisuke Miyaki, Nobuhiko Hiraga, Michio Imamura, et al.Journal of Viral Hepatitis|December 28, 2022
A novel cDNA-uPA/SCID/Rag2-/- /Jak3-/- mouse model for hepatitis virus infection and reconstruction of human immune systemTakuro Uchida, Yuji Teraoka, Michio Imamura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 12, 2024
Interleukin-33 and liver natural killer cells: A novel perspective on antitumor activity in liver fibrosisYuki Imaoka, Masahiro Ohira, Kouki Imaoka, et al.Scandinavian Journal of Gastroenterology|July 29, 2010
Prolongation of interferon therapy for recurrent hepatitis C after living donor liver transplantation: analysis of predictive factors of sustained virological response, including amino acid sequence of the core and NS5A regions of hepatitis C virusTomokazu Kawaoka, Nobuhiko Hiraga, Shoichi Takahashi, et al.Cancer Chemotherapy and Pharmacology|March 22, 2023
A prospective feasibility study of uracil-tegafur and leucovorin as adjuvant chemotherapy for patients aged ≥ 80 years after curative resection of colorectal cancer, the HiSCO-03 studyHiroshi Okuda, Manabu Shimomura, Satoshi Ikeda, et al.Transplantation Proceedings|March 5, 2024
Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular CarcinomaKouki Imaoka, Masahiro Ohira, Minoru Hattori, et al.Transplantation Direct|August 9, 2016
Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide SurveySusumu Eguchi, Hiroyuki Furukawa, Shinji Uemoto, et al.Pageof 65